Differential Expression and Pharmacology of Native P2X Receptors in Rat and Primate Sensory Neurons

Overview

Journal J Neurosci

Specialty Neurology

Date 2012 Aug 24

PMID 22915129

Citations 23

Authors

Alexandre Serrano

Gary Mo

Rebecca Grant

Michel Pare

Dajan ODonnell

Xiao Hong Yu

Miroslaw J Tomaszewski

Martin N Perkins

Philippe Seguela

Chang Qing Cao

Affiliations

Soon will be listed here.

Abstract

Evidence suggesting the involvement of P2X2 and P2X3 in chronic pain has been obtained mostly from rodent models. Here we show that rodents may be poor predictors of P2X3 pharmacology in human. We demonstrate that monkey and human dorsal root ganglion (DRG) neurons do not express appreciable levels of P2X2 subunit, contrary to rat sensory neurons. Additionally, we report functional P2X3 activity in monkey DRG neurons and confirm the absence of functional P2X2/3 receptors. Interestingly, native P2X3 receptors in rat and monkey DRGs show similar agonist potency, but different antagonist potencies for TNP-ATP [2-O-(2,4,6-trinitrophenyl)-ATP] and RO51. This unexpected difference in antagonist potency was confirmed by comparing rat and human P2X3 receptors in HEK293 cells. Mutagenesis studies reveal that two extracellular residues, A197 and T202, are synergistically responsible for the potency drop in primate P2X3 receptors. These results uncover species-specific P2X3 pharmacology and identify key mechanisms impacting the translatability of potential analgesics targeting P2X3 receptors.

Citing Articles

Data science in drug discovery safety: Challenges and opportunities.

Coltman N, Roberts R, Sidaway J Exp Biol Med (Maywood). 2023; 248(21):1993-2000.

PMID: 38062553 PMC: 10798188. DOI: 10.1177/15353702231215890.

Role of ATP in migraine mechanisms: focus on P2X3 receptors.

Giniatullin R, Nistri A J Headache Pain. 2023; 24(1):1.

PMID: 36597043 PMC: 9809127. DOI: 10.1186/s10194-022-01535-4.

BzATP Activates Satellite Glial Cells and Increases the Excitability of Dorsal Root Ganglia Neurons In Vivo.

Chen Z, Zhang C, Song X, Cui X, Liu J, Ford N Cells. 2022; 11(15).

PMID: 35892578 PMC: 9330736. DOI: 10.3390/cells11152280.

P2X3-selective mechanism of Gefapixant, a drug candidate for the treatment of refractory chronic cough.

Cui W, Wang S, Zhang Y, Wang Y, Fan Y, Guo C Comput Struct Biotechnol J. 2022; 20:1642-1653.

PMID: 35465163 PMC: 9014320. DOI: 10.1016/j.csbj.2022.03.030.

Specific Attenuation of Purinergic Signaling during Bortezomib-Induced Peripheral Neuropathy In Vitro.

Holzer A, Suciu I, Karreman C, Goj T, Leist M Int J Mol Sci. 2022; 23(7).

PMID: 35409095 PMC: 8998302. DOI: 10.3390/ijms23073734.

References

Sokolova E, Skorinkin A, Moiseev I, Agrachev A, Nistri A, Giniatullin R . Experimental and modeling studies of desensitization of P2X3 receptors. Mol Pharmacol. 2006; 70(1):373-82. DOI: 10.1124/mol.106.023564. View

Barclay J, Patel S, Dorn G, Wotherspoon G, Moffatt S, Eunson L . Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J Neurosci. 2002; 22(18):8139-47. PMC: 6758070. View

Gever J, Cockayne D, Dillon M, Burnstock G, Ford A . Pharmacology of P2X channels. Pflugers Arch. 2006; 452(5):513-37. DOI: 10.1007/s00424-006-0070-9. View

Bodnar M, Wang H, Riedel T, Hintze S, Kato E, Fallah G . Amino acid residues constituting the agonist binding site of the human P2X3 receptor. J Biol Chem. 2010; 286(4):2739-49. PMC: 3024770. DOI: 10.1074/jbc.M110.167437. View

Chen Y, Li G, Wang C, Gu Y, Huang L . Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state. Pain. 2005; 119(1-3):38-48. DOI: 10.1016/j.pain.2005.09.007. View

Cockayne D, HAMILTON S, Zhu Q, Dunn P, Zhong Y, Novakovic S . Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature. 2000; 407(6807):1011-5. DOI: 10.1038/35039519. View

Ford A . In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization. Purinergic Signal. 2011; 8(Suppl 1):3-26. PMC: 3265711. DOI: 10.1007/s11302-011-9271-6. View

Mo G, Grant R, ODonnell D, Ragsdale D, Cao C, Seguela P . Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase C. Mol Pain. 2011; 7:14. PMC: 3050763. DOI: 10.1186/1744-8069-7-14. View

Mennicken F, Zhang J, Hoffert C, Ahmad S, Beaudet A, ODonnell D . Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol. 2003; 465(3):349-60. DOI: 10.1002/cne.10839. View

10.

Kaan T, Yip P, Patel S, Davies M, Marchand F, Cockayne D . Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain. 2010; 133(9):2549-64. DOI: 10.1093/brain/awq194. View

11.

Collo G, North R, Kawashima E, Merlo-Pich E, Neidhart S, Surprenant A . Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci. 1996; 16(8):2495-507. PMC: 6578782. View

12.

Matsuka Y, Ono T, Iwase H, Mitrirattanakul S, Omoto K, Cho T . Altered ATP release and metabolism in dorsal root ganglia of neuropathic rats. Mol Pain. 2008; 4:66. PMC: 2630978. DOI: 10.1186/1744-8069-4-66. View

13.

Tsuzuki K, Kondo E, Fukuoka T, Yi D, Tsujino H, Sakagami M . Differential regulation of P2X(3) mRNA expression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia. Pain. 2001; 91(3):351-360. DOI: 10.1016/S0304-3959(00)00456-5. View

14.

Carter D, Alam M, Cai H, Dillon M, Ford A, Gever J . Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain. Bioorg Med Chem Lett. 2009; 19(6):1628-31. DOI: 10.1016/j.bmcl.2009.02.003. View

15.

Kobayashi K, Fukuoka T, Yamanaka H, Dai Y, Obata K, Tokunaga A . Differential expression patterns of mRNAs for P2X receptor subunits in neurochemically characterized dorsal root ganglion neurons in the rat. J Comp Neurol. 2004; 481(4):377-90. DOI: 10.1002/cne.20393. View

16.

Jarvis M, Wismer C, Schweitzer E, Yu H, van Biesen T , Lynch K . Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue. Br J Pharmacol. 2001; 132(1):259-69. PMC: 1572551. DOI: 10.1038/sj.bjp.0703793. View

17.

Pankratov YuV , Lalo U, Dashkin A, Krishtal A . Heterogeneity of the functional expression of P2X3 and P2X2/3 receptors in the primary nociceptive neurons of rat. Neurochem Res. 2001; 26(8-9):993-1000. DOI: 10.1023/a:1012344803672. View

18.

Xiang Z, Bo X, Burnstock G . Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia. Neurosci Lett. 1998; 256(2):105-8. DOI: 10.1016/s0304-3940(98)00774-5. View

19.

Cockayne D, Dunn P, Zhong Y, Rong W, Hamilton S, Knight G . P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol. 2005; 567(Pt 2):621-39. PMC: 1474198. DOI: 10.1113/jphysiol.2005.088435. View

20.

Mogil J, Davis K, Derbyshire S . The necessity of animal models in pain research. Pain. 2010; 151(1):12-17. DOI: 10.1016/j.pain.2010.07.015. View